Chief Medical Officer

Spyre Therapeutics Completes $316 Million Public Offering

Spyre Therapeutics, Inc. Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Gross Proceeds of $316.2 Million

Spyre Therapeutics Closes $316.2 Million Public Offering

Spyre Therapeutics Launches Public Offering

Director, Supply Chain

Spyre Therapeutics is a clinical-stage biotechnology company focused on developing innovative treatments for inflammatory bowel disease and other immune-mediated diseases. They are seeking an experienced Director of Supply Chain to lead clinical supply efforts, ensuring compliance and efficiency throughout clinical studies while managing vendor relationships and supply chain processes.

SVP, People

Senior Vice President Operations

Sr. Director, Supply Chain

Senior Director, Clinical Operations

Director, Sr. Paralegal and Legal Operations Lead

Sign up with Google

Sign in with Google